verified SJR 0,685 · Q2 • database Scopus / SJR & Web of Science indexed

United States · Lippincott Williams and Wilk...

workspace_premium Q2 — Psychiatry and Mental Health lock Subscription

Alzheimer Disease and Associated Disorders

Alzheimer Disease and Associated Disorders is a journal indexed in SJR in Psychiatry and Mental Health and Clinical Psychology with an H index of 111. It has an SJR impact factor of 0,685 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,685.

Alzheimer Disease and Associated Disorders focuses its scope in these topics and keywords: cognitive, impairment, alzheimer, mild, disease, hippocampal, populationbased, peptide, predict, quality, ...

ISSN: 0893-0341

Publisher: Lippincott Williams and Wilkins Ltd.

Category: Psychiatry and Mental Health

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,685 Q2

H-index 111

Acceptance rate pie_chart

24% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,685

H-index

111

Docs (year)

Docs 3y

193

Total refs

1804

Cites 3y

343

Citable 3y

184

Cites/Doc 2y

1.48

Ref/Doc

30.58

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Alzheimer Disease Biomarkers as Outcome Measures for Clinical Trials in MCI

Younger Age at Crisis Following Parental Death in Male Children and Adolescents Is Associated With Higher Risk for Dementia at Old Age

Cerebral Blood Flow and Metabolism

Brain Acetylcholinesterase Activity in Alzheimer Disease Measured by Positron Emission Tomography

Benzodiazepines May Have Protective Effects Against Alzheimer Disease

Behavioral Quantitation Is More Sensitive Than Cognitive Testing in Frontotemporal Dementia

Autopsy Recruitment Program for African Americans

Autopsy Practices at CERAD and Alzheimer Disease Center Sites

Association of Body Fat Percentage and Waist-hip Ratio With Brain Cortical Thickness

Anosognosia in Alzheimer Disease

Angina Pectoris Severity Among Coronary Heart Disease Patients is Associated With Subsequent Cognitive Impairment

Alzheimer Disease: Current Therapy and Future Therapeutic Strategies

SHOW MORE ARTICLES

Alzheimer Disease: Absolute Quantification of Cerebral Metabolites In Vivo Using Localized Proton Magnetic Resonance Spectroscopy

A 24-Week, Open-Label Extension Study to Investigate the Long-term Safety, Tolerability, and Efficacy of 13.3 mg/24 h Rivastigmine Patch in Patients With Severe Alzheimer Disease

Agreement on Diagnosis Among Patients, Companions, and Professionals After a Dementia Evaluation

Age at Onset and Visuocognitive Disturbances in Alzheimer Disease

Advance Consent for Dementia Research

Adult-Onset Hallervorden-Spatz Syndrome Presenting As Cortical Dementia

Activation Mechanism of Brain Microglia in Patients With Diffuse Neurofibrillary Tangles With Calcification: A Comparison With Alzheimer Disease

Abnormally Phosphorylated Tau Protein in Senile Dementia of Lewy Body Type and Alzheimer Disease

a-1-Antichymotrypsin and Oxidative Stress in the Peripheral Blood From Patients With Probable Alzheimer Disease: A Short-Term Longitudinal Study

A Systematic Review of the Public's Knowledge and Understanding of Alzheimer's Disease and Dementia

A Review of Psychosocial Models in Psychogeriatrics: Implications for Care and Research

A Prospective Comparison of Informant-based and Performance-based Dementia Screening Tools to Predict In-Hospital Delirium

FAQs

Alzheimer Disease and Associated Disorders has an SJR of 0,685 (best quartile Q2) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Alzheimer Disease and Associated Disorders is 24%.

Alzheimer Disease and Associated Disorders

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Alzheimer Disease and Associated Disorders?

What is the APC / publication cost?

What is the acceptance rate?